Instadose Pharma Corp.

INSD

US45783B1035

Home Furnishings

Delayed OTC Markets Other stock markets 15:34:47 2023-12-29 EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2023	TetraPharma Royalty Corp. acquired TetraPharma Ltd. from Instadose Pharma Corp..	CI
2023	An unknown buyer entered into an agreement to acquire TetraPharma Ltd. from Instadose Pharma Corp. for $0.0001 million.	CI

Instadose Pharma Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2021

October 13, 2021 at 05:16 pm

Instadose Pharma Corp. announced earnings results for the third quarter ended August 31, 2021. For the third quarter, the company announced net loss was USD 52,829 compared to USD 4,143 a year ago. For the nine months, net loss was USD 112,960 compared to USD 17,749 a year ago.

Latest news about Instadose Pharma Corp.

TetraPharma Royalty Corp. acquired TetraPharma Ltd. from Instadose Pharma Corp..	23-09-18	CI
An unknown buyer entered into an agreement to acquire TetraPharma Ltd. from Instadose Pharma Corp. for $0.0001 million.	23-07-06	CI
Instadose Pharma Corp. Announces Board Changes	22-11-07	CI
Instadose Pharma Corp. Announces Resignation of Alex Wylie as Chief Financial Officer	22-11-07	CI
Instadose Pharma Corp. Announces CEO Changes	22-11-07	CI
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	22-05-09	CI
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	22-05-09	CI
Instadose Pharma Corp. Reports Earnings Results for the Full Year Ended November 30, 2021	22-03-15	CI
Instadose Pharma Corp. Announces Management Transition	22-01-14	CI
Instadose Pharma Corp. completed the acquisition of Mikrocoze Inc. in a reverse merger transaction.	21-12-30	CI
Instadose Pharma Corp. Establishes New Supply Route from South Africa to North Macedonia	21-10-25	CI
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2021	21-10-13	CI
Instadose Pharma Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2021	21-07-14	CI
Instadose Pharma Corp. Reports Earnings Results for the First Quarter Ended February 28, 2021	21-04-14	CI
Mikrocoze Inc. Reports Earnings Results for the Full Year Ended November 30, 2020	21-02-25	CI
Instadose Pharma Corp. entered into a non-binding letter of intent to acquire Mikrocoze Inc. for $0.03 million in a reverse merger transaction.	20-12-06	CI
Mikrocoze Inc. Ceases Sukhmanjit Singh as Chief Executive Officer	20-11-06	CI
Mikrocoze Inc. Ceases Sukhmanjit Singh as Chief Financial Officer	20-11-06	CI
Mikrocoze Inc. Announces Executive Changes	20-11-06	CI
Mikrocoze Inc. Reports Earnings Results for the Third Quarter Ended August 31, 2020	20-10-15	CI
Mikrocoze Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2020	20-07-20	CI
Mikrocoze Inc. Reports Earnings Results for the First Quarter Ended February 29, 2020	20-04-14	CI
Mikrocoze Inc. Reports Earnings Results for the Full Year Ended November 30, 2019	20-03-03	CI
Mikrocoze Inc. Reports Earnings Results for the Third Quarter Ended August 31, 2019	19-10-11	CI
Mikrocoze Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2019	19-07-15	CI

Chart Instadose Pharma Corp.

Duration

Period

More charts

Company Profile

IDP Holdings (USA) Corp., formerly Instadose Pharma Corp. (Instadose Canada), is a holding company. The Company, through its wholly owned subsidiary, Instadose Canada is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil (Global Distribution Platform). Instadose Canadaâs Global Distribution Platform spans five continents, including Africa, Europe, Asia, South America, and North America. Its Global Distribution Platform functions include organizing, managing, and sourcing the transport of medicinal cannabis from medicinal cannabis cultivation participants to one or more cannabinoid oil production participants; selling all medicinal cannabis and cannabinoid oil cultivated and/or produced by global distribution platform participants to pharmaceutical industry companies, and sourcing new medicinal cannabis cultivation and cannabinoid oil production participants across new and existing continents.

Sector

Home Furnishings

More about the company

Income Statement Evolution

More financial data

Sector Other Home Furnishings

	1st Jan change	Capi.
INSTADOSE PHARMA CORP.	-.--%	531
MAN WAH HOLDINGS LIMITED	+18.32%	3.19B
LEGGETT & PLATT, INCORPORATED	-53.10%	1.67B
ZIEL HOME FURNISHING TECHNOLOGY CO., LTD.	+13.38%	1.45B
LUOLAI LIFESTYLE TECHNOLOGY CO., LTD.	-2.80%	1.03B
LOCTEK ERGONOMIC TECHNOLOGY CORP.	-2.62%	736M
SHANGHAI SHUIXING HOME TEXTILE CO., LTD.	+32.20%	666M
DER FUTURE SCIENCE AND TECHNOLOGY HOLDING GROUP CO., LTD.	-21.77%	429M
ZHEJIANG ZHENGTE CO., LTD.	-2.91%	337M
VICTORIAN PLUMBING GROUP PLC	-14.32%	321M

Other Home Furnishings